BR1100983A - Novos compostos derivados de bezimidazol, processo de preparação dos compostos, composições farmacêuticas, e, utilização dos derivados - Google Patents

Novos compostos derivados de bezimidazol, processo de preparação dos compostos, composições farmacêuticas, e, utilização dos derivados

Info

Publication number
BR1100983A
BR1100983A BR1100983-7A BR1100983A BR1100983A BR 1100983 A BR1100983 A BR 1100983A BR 1100983 A BR1100983 A BR 1100983A BR 1100983 A BR1100983 A BR 1100983A
Authority
BR
Brazil
Prior art keywords
radical
alkyl
hydroxyl
bezimidazole
derivatives
Prior art date
Application number
BR1100983-7A
Other languages
English (en)
Inventor
Maria Rosa Cuberes-Altisent
Jordi Frigola-Constansa
Juan Pares Corominas
Original Assignee
Maria Rosa Cuberes-Altisent
Jordi Frigola-Constansa
Juan Pares Corominas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maria Rosa Cuberes-Altisent, Jordi Frigola-Constansa, Juan Pares Corominas filed Critical Maria Rosa Cuberes-Altisent
Publication of BR1100983A publication Critical patent/BR1100983A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Anesthesiology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BR1100983-7A 1991-04-05 1997-05-14 Novos compostos derivados de bezimidazol, processo de preparação dos compostos, composições farmacêuticas, e, utilização dos derivados BR1100983A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9104171A FR2674856B1 (fr) 1991-04-05 1991-04-05 Nouveaux antihistaminiques non sedatifs, derives de benzimidazole, leur procede de preparation et leur utilisation en tant que medicaments.

Publications (1)

Publication Number Publication Date
BR1100983A true BR1100983A (pt) 1999-10-13

Family

ID=9411523

Family Applications (1)

Application Number Title Priority Date Filing Date
BR1100983-7A BR1100983A (pt) 1991-04-05 1997-05-14 Novos compostos derivados de bezimidazol, processo de preparação dos compostos, composições farmacêuticas, e, utilização dos derivados

Country Status (28)

Country Link
US (1) US5214040A (pt)
EP (1) EP0507696B1 (pt)
JP (1) JP3060054B2 (pt)
KR (1) KR970011298B1 (pt)
CN (1) CN1028367C (pt)
AT (1) ATE126228T1 (pt)
AU (1) AU647904B2 (pt)
BG (1) BG60678B1 (pt)
BR (1) BR1100983A (pt)
CA (1) CA2065061A1 (pt)
CZ (1) CZ279506B6 (pt)
DE (1) DE69203911T2 (pt)
DK (1) DK0507696T3 (pt)
ES (1) ES2046110B1 (pt)
FI (1) FI99112C (pt)
FR (1) FR2674856B1 (pt)
GR (1) GR3017643T3 (pt)
HU (1) HU214316B (pt)
IL (1) IL101483A (pt)
IS (1) IS1639B (pt)
MX (1) MX9201556A (pt)
NO (1) NO179552C (pt)
NZ (1) NZ242208A (pt)
PL (1) PL167720B1 (pt)
RO (1) RO109198B1 (pt)
RU (1) RU2099336C1 (pt)
TW (1) TW208003B (pt)
YU (1) YU48826B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264456B1 (it) * 1993-05-14 1996-09-23 Dompe Farmaceutici Spa Derivati del 2-(benzimidazol-2-il)-1,3-diaminopropano farmacologicamente attivi.
FR2727865B1 (fr) * 1994-12-08 1997-07-18 Esteve Labor Dr Utilisation des derives de 2-(4-(azolybutyl)-piperazinyl- (methyl))-benzimidazole et analogues ainsi que de leurs sels, pour la preparation de medicaments destines au traitement ou a la prophylaxie de l'asthme
US5773616A (en) * 1995-02-15 1998-06-30 Neurogen Corporation Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands
CA2213197C (en) * 1995-02-15 2001-08-07 Neurogen Corporation Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands
FR2731618B1 (fr) * 1995-03-14 1997-08-01 Esteve Labor Dr Composition ophtalmique topique comprenant un derive de 2-(4-(azolylbutyl)-piperazinyl-methyl)-benzimidazole, notamment pour le traitement de la conjonctivite allergique
US6211199B1 (en) 1995-11-17 2001-04-03 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
US6423704B2 (en) 1995-12-20 2002-07-23 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases
US6194406B1 (en) 1995-12-20 2001-02-27 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease
US5922737A (en) * 1996-02-21 1999-07-13 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases
US5932571A (en) * 1996-02-21 1999-08-03 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) {1,4}diazepan-1-yl)-2-(aryl) butyl) benzamides useful for the treatment of allergic diseases
US5998439A (en) 1996-02-21 1999-12-07 Hoescht Marion Roussel, Inc. Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
TWI225488B (en) * 1999-12-21 2004-12-21 Janssen Pharmaceutica Nv Derivatives of homopiperidinyl substituted benzimidazole analogues
HU230609B1 (hu) * 2000-01-19 2017-03-28 Cadila Healthcare Ltd. Hipolipidémiás és hipokoleszterinémiás hatású szubsztituált pirrolszármazékok, azokat tartalmazó gyógyszerkészítmények, eljárás előállításukra, köztitermékek és alkalmazásuk
CZ2003952A3 (cs) * 2000-10-31 2003-11-12 Basf Drucksysteme Gmbh Použití hyperrozvětvených polyurethanů
CA2473236A1 (en) * 2002-01-10 2003-07-24 Neurogen Corporation Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1h-benzoimidazole analogues
CN101089000B (zh) * 2006-06-16 2011-01-05 北京大学 螺环哌嗪季铵盐类化合物及其制备方法和应用
MX2011013294A (es) * 2009-06-11 2012-01-12 Siena Biotech Spa Antagonistas de la trayectoria de hedgehog y aplicaciones terapeuticas de los mismos.
PT2938597T (pt) * 2012-12-27 2016-12-09 Université De Lille 2 Droit Et Santé Sais sulfato de n-(3-(4-(3-(isobutilamino)propil)-piperazin-1-il)propil)-1h-benzo[d]imidazol-2-amina, sua preparação e sua utilização
KR102057075B1 (ko) * 2018-11-30 2019-12-19 우승열 페트병에 장착되는 여과장치

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200641A (en) * 1976-12-21 1980-04-29 Janssen Pharmaceutica, N.V. 1-[(Heterocyclyl)-alkyl]-4-diarylmethoxy piperidine derivatives
DE3336409A1 (de) * 1983-10-06 1985-04-18 Ludwig Heumann & Co GmbH, 8500 Nürnberg Chinazolinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US5010075A (en) * 1987-04-24 1991-04-23 Syntex Pharmaceuticals Ltd. Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives
CA1317939C (en) * 1987-07-01 1993-05-18 Janssen Pharmaceutica Naamloze Vennootschap ¬(bicyclic heterocyclyl)methyl and -hetero| substituted hexahydro-1h-azepines and pyrrolidines
FR2665161B1 (fr) * 1990-07-26 1992-11-27 Esteve Labor Dr Nouveaux derives de benzimidazole, leur preparation et leur application en tant que medicaments.

Also Published As

Publication number Publication date
HU9201145D0 (en) 1992-06-29
HUT60732A (en) 1992-10-28
JPH0597846A (ja) 1993-04-20
CZ279506B6 (cs) 1995-05-17
FI921473A (fi) 1992-10-06
PL167720B1 (pl) 1995-10-31
IL101483A (en) 1995-12-08
MX9201556A (es) 1992-10-01
AU1397992A (en) 1992-10-08
HU214316B (hu) 1998-03-02
ES2046110A1 (es) 1994-01-16
NO921315L (no) 1992-10-06
CS101792A3 (en) 1992-10-14
ES2046110B1 (es) 1994-08-01
FR2674856B1 (fr) 1993-07-30
YU48826B (sh) 2002-03-18
RU2099336C1 (ru) 1997-12-20
GR3017643T3 (en) 1996-01-31
ATE126228T1 (de) 1995-08-15
CN1028367C (zh) 1995-05-10
BG60678B1 (bg) 1995-12-29
EP0507696B1 (fr) 1995-08-09
IS3832A (is) 1992-10-06
AU647904B2 (en) 1994-03-31
US5214040A (en) 1993-05-25
FR2674856A1 (fr) 1992-10-09
DK0507696T3 (da) 1995-09-18
DE69203911D1 (de) 1995-09-14
CN1065460A (zh) 1992-10-21
EP0507696A1 (fr) 1992-10-07
NZ242208A (en) 1993-10-26
IS1639B (is) 1997-03-25
KR970011298B1 (ko) 1997-07-09
NO179552B (no) 1996-07-22
KR920019781A (ko) 1992-11-20
PL294101A1 (en) 1992-11-30
JP3060054B2 (ja) 2000-07-04
FI99112C (fi) 1997-10-10
NO921315D0 (no) 1992-04-03
CA2065061A1 (fr) 1992-10-06
IL101483A0 (en) 1992-12-30
FI921473A0 (fi) 1992-04-03
DE69203911T2 (de) 1995-12-07
RO109198B1 (ro) 1994-12-30
NO179552C (no) 1996-10-30
TW208003B (pt) 1993-06-21
YU33692A (sh) 1995-03-27
FI99112B (fi) 1997-06-30

Similar Documents

Publication Publication Date Title
BR1100983A (pt) Novos compostos derivados de bezimidazol, processo de preparação dos compostos, composições farmacêuticas, e, utilização dos derivados
HUT59394A (en) Process for producing piperazine derivatives and pharmaceutical compositions comprising same
FR2665161B1 (fr) Nouveaux derives de benzimidazole, leur preparation et leur application en tant que medicaments.
DK0556813T3 (da) Amfotere tricykliske forbindelser som antihistaminske og antiallergiske midler

Legal Events

Date Code Title Description
AN Processing applications according to articles 230 and 231 of law 9279/96: notification of filing an application
HHFK Processing applications according to articles 230 and 231 of law 9.279/96: republication
MT Patent procedure suspended until requirement met - articles 230 and 231 of law 9279/96
FGAN Processing applications according to articles 230 and 231 of law 9.279/96: granting
NB Patent issued - articles 230 and 231 of law 9279/96